|
ChromaDex® Receives ISO/IEC 17025:2005 Certification - Oct 30, 2013 http://investors.chromadex.com/phoenix.zhtml?c=212121&p=irol… "IRVINE, Calif., Oct. 30, 2013 /PRNewswire/ -- ChromaDex Corp.® (OTCQB: CDXC), an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today that the ChromaDex analytics laboratory located in Boulder, Colorado has received the internationally recognized ISO (International Organization for Standardization) and IEC (International Electrotechnical Commission) 17025:2005 accreditation. The ISO/IEC accreditation, which demonstrates technical competence for a defined testing scope and the operation of a laboratory quality management system, was granted by ACLASS, an ANSI-ASQ National Accreditation Board agency. ISO/IEC 17025 is the international standard by which a laboratory's commitment to quality is evaluated. ChromaDex achieved this accreditation by demonstrating technical competence for the testing of dietary supplements. Competence requirements include testing performed using standard and/or non-standard methods and laboratory-developed methods. ISO 17025 not only considers the management and technical expertise, but also emphasizes continuous process improvement. Commenting on the announcement, Frank Jaksch, ChromaDex Founder and CEO, states, "Receiving the ISO/IEC 17025 accreditation is a testament to our commitment for maintaining quality and excellence in our testing practices. The accreditation provides our customers with the utmost confidence that the accuracy of testing results produced by ChromaDex will carry a high degree of credibility and acceptance." Mark Jost, Vice President of ChromaDex added, "ISO 17025 was identified as a key objective in our strategic planning process. Achieving the accreditation was a result of hard work and dedication by the entire ChromaDex laboratory staff." About ChromaDex®: ChromaDex® is an innovative natural products company that discovers, acquires, develops and commercializes proprietary-based ingredient technologies through its unique business model that utilizes its wholly owned synergistic business units, including ingredient technologies, natural product fine chemicals (known as "phytochemicals"), chemistry and analytical testing services, and product regulatory and safety consulting (as Spherix Consulting). The company provides seamless science-based solutions to the nutritional supplement, food and beverage, animal health, cosmetic and pharmaceutical industries. The ChromaDex ingredient technologies unit includes products backed with extensive scientific research and intellectual property. Its ingredient portfolio includes pTeroPure® pterostilbene; ProC3G™, a natural black rice containing cyanidin-3-glucoside; PURENERGY™, a caffeine-pTeroPure co-crystal; and NIAGEN™, its recently launched branded nicotinamide riboside, a novel next-generation B vitamin. To learn more about ChromaDex, visit www.chromadex.com. " |
|
| aus der Diskussion: | ChromaDex (smallcap) - A Philipp Frost (Billionair) Investment |
| Autor (Datum des Eintrages): | Popeye82 (08.11.13 22:38:01) |
| Beitrag: | 58 von 129 (ID:45796852) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |